HAWKINS WILLIAM A
SEC CIK 1106508 · EDGAR
BoughtSold
Most active insiders at MDXG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Maersk-Moller Kimberly | Chief Commercial Off | — | $432.6K |
| 2 | Whitlow Ricci S | COO | — | — |
| 3 | Hulse William Frank IV | GC, CAO | — | — |
| 4 | DOUG RICE | CFO | — | — |
| 5 | Newton Todd | Dir | — | — |
| 6 | Capper Joseph H | CEO | — | — |
| 7 | Olson Tiffany | Dir | — | — |
| 8 | PUHY DOROTHY E | Dir | — | — |
| 9 | BIERMAN JAMES L | Dir | — | — |
| 10 | HAWKINS WILLIAM A | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-12 11:30 | 2026-06-10 | MDXG | MIMEDX GROUP, INC. | HAWKINS WILLIAM A | Dir | A - Grant | $3.64 | +50.9K | 254.9K | +25% | +$185.3K | |
| 2026-06-11 17:50 | 2026-06-09 | BIIB | Biogen | HAWKINS WILLIAM A | Dir | A - Grant | $0.00 | +1,505 | 10.4K | +17% | $0 | |
| D | 2026-06-04 16:46 | 2026-06-02 | BVS | Bioventus Inc. | HAWKINS WILLIAM A | Dir | M - OptEx | $0.00 | +39.8K | 297.6K | +15% | $0 |
| 2025-06-23 | 2025-06-18 | MDXG | MIMEDX GROUP, INC. | HAWKINS WILLIAM A | Dir | A - Grant | $6.47 | +28.6K | 204.0K | +16% | +$185.1K | |
| 2025-06-18 | 2025-06-17 | BIIB | Biogen | HAWKINS WILLIAM A | Dir | A - Grant | $0.00 | +2,370 | 8,860 | +37% | $0 | |
| D | 2025-06-04 | 2025-06-02 | BVS | Bioventus Inc. | HAWKINS WILLIAM A | Dir | M - OptEx | $0.00 | +26.5K | 257.9K | +11% | $0 |
| 2024-06-25 | 2024-06-21 | BIIB | Biogen | HAWKINS WILLIAM A | Dir | A - Grant | $0.00 | +1,340 | 6,490 | +26% | $0 | |
| D | 2024-06-11 | 2024-06-07 | BVS | Bioventus Inc. | HAWKINS WILLIAM A | Dir | M - OptEx | $0.00 | +30.4K | 231.4K | +15% | $0 |
| 2024-06-06 | 2024-06-05 | MDXG | MIMEDX GROUP, INC. | HAWKINS WILLIAM A | Dir | A - Grant | $7.26 | +23.2K | 175.4K | +15% | +$168.4K | |
| 2023-06-28 | 2023-06-26 | BIIB | Biogen | HAWKINS WILLIAM A | Dir | A - Grant | $0.00 | +960 | 5,150 | +23% | $0 | |
| 2023-06-15 | 2023-06-13 | MDXG | MIMEDX GROUP, INC. | HAWKINS WILLIAM A | Dir | A - Grant | $4.95 | +35.4K | 152.2K | +30% | +$175.0K | |
| D | 2023-06-08 | 2023-06-06 | BVS | Bioventus Inc. | HAWKINS WILLIAM A | Dir | M - OptEx | $0.00 | +16.6K | 201.0K | +9% | $0 |
| M | 2023-05-26 | 2023-05-24+ | BVS | Bioventus Inc. | HAWKINS WILLIAM A | Dir | P - Purchase | $2.67 | +88.0K | 184.3K | +91% | +$235.4K |
| D | 2023-03-16 | 2023-03-14 | BVS | Bioventus Inc. | HAWKINS WILLIAM A | Dir | M - OptEx | — | +3,949 | 96.3K | +4% | — |
| 2022-06-17 | 2022-06-15 | BIIB | Biogen | HAWKINS WILLIAM A | Dir | A - Grant | $0.00 | +1,370 | 4,190 | +49% | $0 | |
| 2022-06-13 | 2022-06-07 | MDXG | MIMEDX GROUP, INC. | HAWKINS WILLIAM A | Dir | A - Grant | $3.96 | +44.2K | 116.9K | +61% | +$175.0K | |
| D | 2022-04-05 | 2022-04-01 | BVS | Bioventus Inc. | HAWKINS WILLIAM A | Dir | M - OptEx | — | +40.6K | 92.4K | +78% | — |
| D | 2022-02-15 | 2022-02-11 | BVS | Bioventus Inc. | HAWKINS WILLIAM A | Dir | M - OptEx | — | +13.5K | 51.8K | +35% | — |
| D | 2022-02-14 | 2022-02-10 | BVS | Bioventus Inc. | HAWKINS WILLIAM A | Dir | M - OptEx | — | +38.3K | 38.3K | New | — |
| 2021-07-02 | 2021-07-01 | BIIB | Biogen | HAWKINS WILLIAM A | Dir | A - Grant | $0.00 | +775 | 2,820 | +38% | $0 |
Purchase Sale Sale after option exercise All abbreviations